The National Institute on Drug Abuse (NIDA) offers this grant for a Coordinating Center (CC) for its HIV/AIDS and Substance Use Cohorts Program. This CC will optimize the utilization of rich data and biospecimens from existing longitudinal cohorts, which are vital for research on HIV pathogenesis, prevention, treatment, and co-morbidities related to substance abuse. The CC’s role includes fostering collaborations among investigators, establishing a virtual repository, and facilitating the Cohorts Steering Committee’s leadership. This grant ensures efficient leverage of these valuable research resources to advance critical HIV/AIDS research.
Opportunity ID: 334891
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-22-033 |
| Funding Opportunity Title: | Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 – Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 22, 2021 |
| Last Updated Date: | Jul 22, 2021 |
| Original Closing Date for Applications: | Feb 17, 2022 |
| Current Closing Date for Applications: | Feb 17, 2022 |
| Archive Date: | Mar 25, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The National Institute on Drug Abuse (NIDA) supports a program of longitudinal cohorts to address emerging and high priority research on HIV/AIDS in the context of injection and non-injection substance abuse. These cohorts provide a strong resource platform for current and future collaborative efforts with other investigators to address emerging questions related to HIV pathogenesis, prevention, and treatment in the context of substance abuse, as well as to foster the creativity and efficiency of investigatorinitiated research projects. The diverse research activities among these cohorts include basic immunologic, and virologic studies, as well as studies on HIV prevention and treatment, and the co-morbidities and co-infections associated with HIV and substance abuse. NIDA has determined that a coordinating center (CC) is needed in order to take advantage of these rich sources of data and bio-specimens and optimize collaborations among both the cohort investigators and other researchers not funded under the cohort program. In addition, the CC is expected to establish a virtual repository, and facilitate the leadership of the cohorts steering committee (SC), consisting of representatives from the NIDA-funded cohorts and NIDA staff. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-033.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 334891 Full Announcement-RFA-DA-22-033 -> RFA-DA-22-033-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00269612 | Jan 17, 2022 | Feb 17, 2022 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00268284 | Jan 17, 2022 | Jan 24, 2022 | View |
Package 1
Mandatory forms
334891 RR_SF424_5_0-5.0.pdf
334891 PHS398_CoverPageSupplement_5_0-5.0.pdf
334891 RR_OtherProjectInfo_1_4-1.4.pdf
334891 PerformanceSite_4_0-4.0.pdf
334891 RR_KeyPersonExpanded_4_0-4.0.pdf
334891 RR_Budget_3_0-3.0.pdf
334891 PHS398_ResearchPlan_4_0-4.0.pdf
334891 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
334891 RR_SubawardBudget30_3_0-3.0.pdf
334891 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
334891 RR_SF424_2_0-2.0.pdf
334891 PHS398_CoverPageSupplement_5_0-5.0.pdf
334891 RR_OtherProjectInfo_1_4-1.4.pdf
334891 PerformanceSite_2_0-2.0.pdf
334891 RR_KeyPersonExpanded_2_0-2.0.pdf
334891 RR_Budget_1_4-1.4.pdf
334891 PHS398_ResearchPlan_4_0-4.0.pdf
334891 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
334891 RR_SubawardBudget30_1_4-1.4.pdf
334891 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
